{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:36:43Z","timestamp":1792427803647,"version":"4.5.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":728,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/1469-0691.12041","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T21:46:44Z","timestamp":1348609604000},"page":"53-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":291,"special_numbering":"S7","title":["ESCMID \n\t\t  guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)"],"prefix":"10.1016","volume":"18","author":[{"given":"A.J.","family":"Ullmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Meersseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Petrikkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12041_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib2","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/1469-0691.12041_bib3","first-page":"974","article-title":"Prevention of fungal infections in the immunocompromised host","volume":"4","author":"Mahfouz","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/1469-0691.12041_bib4","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12041_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13693786.2011.587211","article-title":"Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors","volume":"50","author":"Zirkel","year":"2012","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12041_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/502104","article-title":"Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity","volume":"23","author":"Kontoyiannis","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/1469-0691.12041_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","article-title":"Treatment of invasive fungal infections in cancer patients - recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"88","author":"Bohme","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1111\/1469-0691.12041_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib10","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1155\/2010\/357076","article-title":"Canadian clinical practice guidelines for invasive candidiasis in adults","volume":"21","author":"Bow","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1111\/1469-0691.12041_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2334-11-163","article-title":"Five-years surveillance of invasive aspergillosis in a university hospital","volume":"11","author":"Graf","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12041_bib16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib17","first-page":"1440","article-title":"Infection: the new problems","volume":"21","author":"Rubin","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12041_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib20","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1111\/1469-0691.12041_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12041_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1111\/1469-0691.12041_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2141.1999.01465.x","article-title":"A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group","volume":"105","author":"Morgenstern","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/1469-0691.12041_bib24","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1111\/1469-0691.12041_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/1469-0691.12041_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib28","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1592\/phco.27.12.1644","article-title":"Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients","volume":"27","author":"Chou","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12041_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/319211","article-title":"Mortality and costs of acute renal failure associated with amphotericin B therapy","volume":"32","author":"Bates","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib31","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1086\/505969","article-title":"Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries","volume":"43","author":"Ullmann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dki440","article-title":"An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia","volume":"57","author":"Glasmacher","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbmt.2008.02.020","article-title":"Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors","volume":"14","author":"Jathavedam","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/1469-0691.12041_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients","volume":"30","author":"Nucci","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/AAC.44.7.1887-1893.2000","article-title":"Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B","volume":"44","author":"Harousseau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12041_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib37","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.314.7089.1238","article-title":"Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia","volume":"314","author":"Gotzsche","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/1469-0691.12041_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial","volume":"17","author":"Penack","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1111\/1469-0691.12041_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijantimicag.2007.10.001","article-title":"Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study","volume":"31","author":"Cordonnier","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12041_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/48.1.97","article-title":"Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients","volume":"48","author":"Boogaerts","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bmt.1705418","article-title":"A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients","volume":"38","author":"Oren","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12041_bib42","first-page":"CD002033","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","volume":"4","author":"Gotzsche","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/1469-0691.12041_bib43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/10428191003682726","article-title":"Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies","volume":"51","author":"Hirata","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/1469-0691.12041_bib44","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.1997.2473063.x","article-title":"A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients","volume":"98","author":"Prentice","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/1469-0691.12041_bib46","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":"A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia","volume":"29","author":"Maertens","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12041_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/10428190802635500","article-title":"Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders","volume":"50","author":"Tamura","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/1469-0691.12041_bib50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.clinthera.2010.04.005","article-title":"Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis","volume":"32","author":"Kubiak","year":"2010","journal-title":"Clin Ther"},{"key":"10.1111\/1469-0691.12041_bib51","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia","volume":"328","author":"Pizzo","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib52","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0959-8049(95)00619-2","article-title":"Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial","volume":"32A","author":"Viscoli","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1111\/1469-0691.12041_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer","volume":"108","author":"Winston","year":"2000","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12041_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/514672","article-title":"Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia","volume":"27","author":"White","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph\/ABLC Collaborative Study Group","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib56","first-page":"185","article-title":"Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy","volume":"30","author":"Schuler","year":"2007","journal-title":"Onkologie"},{"key":"10.1111\/1469-0691.12041_bib57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12041_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11908-008-0075-y","article-title":"Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients","volume":"10","author":"Maertens","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/1469-0691.12041_bib59","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12041_bib60","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JCM.05316-11","article-title":"Evaluation of Aspergillus PCR protocols for testing serum specimens","volume":"49","author":"White","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12041_bib61","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2009.21.8032","article-title":"Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study","volume":"28","author":"Girmenia","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/1469-0691.12041_bib63","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12281-010-0044-4","article-title":"Invasive candidiasis in neutropenic cancer patients","volume":"5","author":"Gamaletsou","year":"2011","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1111\/1469-0691.12041_bib65","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/33.2.309","article-title":"The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team","volume":"33","author":"Chandrasekar","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib67","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF01967286","article-title":"Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole","volume":"10","author":"Akova","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/clinids\/18.3.298","article-title":"Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome","volume":"18","author":"Akova","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib69","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib71","first-page":"89","article-title":"Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection","volume":"2","author":"Vazquez","year":"2010","journal-title":"HIV AIDS (Auckl)"},{"issue":"Suppl 1","key":"10.1111\/1469-0691.12041_bib72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1439-0507.1996.tb00514.x","article-title":"Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis","volume":"39","author":"Eichel","year":"1996","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12041_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients","volume":"19","author":"Murray","year":"1997","journal-title":"Clin Ther"},{"key":"10.1111\/1469-0691.12041_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12041_bib75","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/31.6.973","article-title":"Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group","volume":"31","author":"Philpott-Howard","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib76","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib77","first-page":"295","article-title":"A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis","volume":"11","author":"Alvarez","year":"1998","journal-title":"Rev Esp Quimioter"},{"key":"10.1111\/1469-0691.12041_bib78","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1310\/hct1104-186","article-title":"Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad\u00ae efficacy and safety (SMiLES)","volume":"11","author":"Vazquez","year":"2010","journal-title":"HIV Clin Trials"},{"key":"10.1111\/1469-0691.12041_bib79","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ejca.2004.03.003","article-title":"An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis","volume":"40","author":"Oude Lashof","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1111\/1469-0691.12041_bib80","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1053\/gast.1996.v111.pm8898629","article-title":"Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis","volume":"111","author":"Barbaro","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12041_bib81","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2007-1005717","article-title":"Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study","volume":"27","author":"Barbaro","year":"1995","journal-title":"Endoscopy"},{"key":"10.1111\/1469-0691.12041_bib82","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/00365549509047076","article-title":"Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study","volume":"27","author":"Barbaro","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases","volume":"46","author":"Arathoon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12041_bib84","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0b013e31817af47a","article-title":"A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis","volume":"48","author":"Vazquez","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/1469-0691.12041_bib85","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib86","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01191-9","article-title":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","volume":"113","author":"Villanueva","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12041_bib87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00126334-200210010-00009","article-title":"Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole","volume":"31","author":"Kartsonis","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/1469-0691.12041_bib88","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.transproceed.2006.03.050","article-title":"Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients","volume":"38","author":"Veroux","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12041_bib89","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib90","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib91","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1086\/513927","article-title":"Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis","volume":"26","author":"Arikan","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib92","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib93","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib94","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib95","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib96","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12041_bib97","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12041_bib98","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1093\/jac\/dkr394","article-title":"Antifungal use influences Candida species distribution and susceptibility in the intensive care unit","volume":"66","author":"Fournier","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib99","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1128\/AAC.00690-11","article-title":"Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France","volume":"55","author":"Blanchard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12041_bib100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid1801.110556","article-title":"Candida spp. with Acquired Echinocandin Resistance, France, 2004-2010(1)","volume":"18","author":"Dannaoui","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib101","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12041_bib102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0002-9343(96)80072-6","article-title":"Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study","volume":"101","author":"Anaissie","year":"1996","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12041_bib103","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JCM.00179-11","article-title":"Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12041_bib104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780500049152","article-title":"Control of a Candida glabrata prosthetic endovascular infection with posaconazole","volume":"44","author":"Anstead","year":"2006","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12041_bib105","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12041_bib106","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10096-003-1014-3","article-title":"Voriconazole salvage treatment of invasive candidiasis","volume":"22","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib107","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc8117","article-title":"Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B","volume":"13","author":"Dupont","year":"2009","journal-title":"Crit Care"},{"key":"10.1111\/1469-0691.12041_bib108","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib109","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1705143","article-title":"Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)","volume":"36","author":"Ito","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 6","key":"10.1111\/1469-0691.12041_bib110","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1086\/429330","article-title":"Treatment of Candida infections with amphotericin B lipid complex","volume":"40","author":"Ito","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib111","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/516314","article-title":"Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients","volume":"26","author":"Noskin","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib112","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.bmt.1701630","article-title":"Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients","volume":"23","author":"Noskin","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12041_bib113","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF01713042","article-title":"A randomized study comparing fluconazole with amphotericin B\/5-flucytosine for the treatment of systemic Candida infections in intensive care patients","volume":"24","author":"Abele-Horn","year":"1996","journal-title":"Infection"},{"key":"10.1111\/1469-0691.12041_bib114","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1128\/AAC.00488-07","article-title":"Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing","volume":"51","author":"Hope","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12041_bib115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/ecp.09.14","article-title":"Antifungal drugs: predicting clinical efficacy with pharmacodynamics","volume":"2","author":"Nailor","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1111\/1469-0691.12041_bib116","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib117","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib118","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jmri.1880020315","article-title":"Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging","volume":"2","author":"Semelka","year":"1992","journal-title":"J Magn Reson Imaging"},{"key":"10.1111\/1469-0691.12041_bib119","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/clinids\/18.6.979","article-title":"Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem","volume":"18","author":"Anttila","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002770050409","article-title":"Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation","volume":"77","author":"Karthaus","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1111\/1469-0691.12041_bib121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000040869","article-title":"Diagnosis and monitoring response to treatment of hepatosplenic candidiasis in patients with acute leukemia using magnetic resonance imaging","volume":"100","author":"Sallah","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1111\/1469-0691.12041_bib122","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/13693780600735445","article-title":"The usefulness of the Platelia Candida antigen in a patient with acute lymphocytic leukemia and chronic disseminated candidiasis","volume":"44","author":"Sun","year":"2006","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12041_bib123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00277-002-0588-7","article-title":"Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis","volume":"82","author":"Chen","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1111\/1469-0691.12041_bib124","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12041_bib125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1399-3062.2009.00363.x","article-title":"Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature","volume":"11","author":"Poon","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib126","first-page":"535","article-title":"Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes","volume":"87","author":"Pagano","year":"2002","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12041_bib127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1081\/PDT-100102037","article-title":"In situ liposomal preparation containing amphotericin B: related toxicity and tissue disposition studies","volume":"5","author":"Chakraborty","year":"2000","journal-title":"Pharm Dev Technol"},{"key":"10.1111\/1469-0691.12041_bib128","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QCO.0b013e32834ab20a","article-title":"Immune reconstitution syndrome and fungal infections","volume":"24","author":"Gupta","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/MPH.0b013e3181b795ec","article-title":"Adjuvant corticosteroid therapy in 2 children with hepatosplenic candidiasis-related IRIS","volume":"31","author":"Saint-Faust","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/1469-0691.12041_bib131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jinf.2008.12.008","article-title":"Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome","volume":"58","author":"Liu","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12041_bib132","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1469-0691.2010.03338.x","article-title":"Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital","volume":"17","author":"Munoz","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12041_bib133","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1128\/JCM.00201-11","article-title":"Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden","volume":"49","author":"Axner-Elings","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12041_bib134","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","article-title":"Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)","volume":"38","author":"Pfaller","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12041_bib135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10096-008-0546-y","article-title":"A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia","volume":"27","author":"Velasco","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib136","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib137","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12041_bib138","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12041_bib139","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/dkr429","article-title":"Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms","volume":"67","author":"Nweze","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9343(96)90006-6","article-title":"Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia","volume":"100","author":"Anaissie","year":"1996","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12041_bib141","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cncr.21142","article-title":"Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia","volume":"104","author":"Dignani","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/1469-0691.12041_bib142","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.21929","article-title":"Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions","volume":"106","author":"Safdar","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/1469-0691.12041_bib143","first-page":"CD005341","article-title":"Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction","volume":"1","author":"Massey","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/1469-0691.12041_bib144","first-page":"362","article-title":"Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients","volume":"82","author":"Di Mario","year":"1997","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12041_bib145","first-page":"910","article-title":"G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1111\/1469-0691.12041_bib146","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402007","article-title":"Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections","volume":"15","author":"Lee","year":"2001","journal-title":"Leukemia"},{"key":"10.1111\/1469-0691.12041_bib147","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1423-0410.2007.00971.x","article-title":"Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions","volume":"93","author":"Ofran","year":"2007","journal-title":"Vox Sang"},{"key":"10.1111\/1469-0691.12041_bib148","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1537-2995.2006.00996.x","article-title":"Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections","volume":"46","author":"Sachs","year":"2006","journal-title":"Transfusion"},{"key":"10.1111\/1469-0691.12041_bib149","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1198-743X.2004.00823.x","article-title":"Caspofungin - a new therapeutic option for oropharyngeal candidiasis","volume":"10","author":"Garbino","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12041_bib150","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jac\/dkh179","article-title":"Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study","volume":"53","author":"Kartsonis","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12041_bib151","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000238877","article-title":"Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients","volume":"37","author":"Krcmery","year":"1991","journal-title":"Chemotherapy"},{"key":"10.1111\/1469-0691.12041_bib152","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-117-8-655","article-title":"Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial","volume":"117","author":"Laine","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12041_bib153","first-page":"175","article-title":"Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study","volume":"27","author":"Barbaro","year":"1995","journal-title":"Ital J Gastroenterol"},{"issue":"Suppl 2","key":"10.1111\/1469-0691.12041_bib154","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/cc2020","article-title":"Itraconazole IV solution in the treatment of candidaemia in non-neutropenic patients","volume":"7","author":"Tuil","year":"2003","journal-title":"Critical Care"},{"issue":"Suppl 7","key":"10.1111\/1469-0691.12041_bib155","first-page":"1","article-title":"ESCMID Diagnostic and Management Guideline for Candida Diseases 2012","volume":"18","author":"Ullmann","year":"2012","journal-title":"Developing European Guidelines in Clinical Microbiology and Infectious Diseases"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:13:33Z","timestamp":1761117213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14607679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":155,"alternative-id":["S1198743X14607679"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12041","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717970484.793469082","asserted-by":"object"}]},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESCMID\n\t\t guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1469-0691.12041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}